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Abstract
Tmub1 (C7orf21/HOPS) encodes a protein containing a ubiquitin-like domain. Tmub1 is highly expressed in the nervous
system. To study its physiological function, we generated mice with Tmub1 deleted by homologous recombination. The
knockout mice were grossly normal and viable. In a comprehensive behavioral testing battery, the only knockout phenotype
displayed was a strong increase in home cage locomotor activity during the dark phase (subjective day) of the light:dark (L:D)
cycle.Therewerenochangesinactivityduringthelightperiod.Therewerenochangesinlocomotor activityobservedinother
assays, e.g. novel open-field. The increase in dark phase locomotor activity persisted during a seven day D:D (complete
darkness) challenge, and remained largely confined to the normally dark period. Telemetric recording in freely moving
subjects for one 24 hr L:D cycle, revealed the same increase in locomotor activity in the dark phase. In addition, EEG analysis
showed that the knockout mice exhibited increased waking and decreased NREM & REM times during the dark phase, but the
EEG was otherwise normal. Using lacZ as a reporter we found Tmub1 expression prominent in a few brain structures including
the thalamus, a region known to drive wakefulness and arousal via its projections to the cortex. We identified calcium
modulating cyclophilin ligand CAMLG/CAML as a binding partner by a yeast two-hybrid screen of a brain library. The
interaction of Tmub1 and CAMLG was confirmed by co-immunoprecipitation assays in HEK cells. The two proteins were also
found to be co-localizedto the cytoplasm when expressed in HEK cells.Both Tmub1 and CAMLG havebeen recently described
intheregulation ofmembranetraffickingofspecificreceptors.TakentogetherourresultsimplicateTmub1inthe regulationof
locomotor activity and wakefulness and suggest that Tmub1 binds to and functions together with CAMLG.
Citation: Zhang W, Savelieva KV, Suwanichkul A, Small DL, Kirkpatrick LL, et al. (2010) Transmembrane and Ubiquitin-Like Domain Containing 1 (Tmub1)
Regulates Locomotor Activity and Wakefulness in Mice and Interacts with CAMLG. PLoS ONE 5(6): e11261. doi:10.1371/journal.pone.0011261
Editor: Georges Chapouthier, L’universite ´ Pierre et Marie Curie, France
Received April 13, 2010; Accepted May 19, 2010; Published June 22, 2010
Copyright:  2010 Zhang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The study was conducted at and financially supported by Lexicon Pharmaceuticals. All authors were employees of Lexicon Pharmaceuticals when
conducting the research of this manuscript. Authors designed the study, conducted data collection and analysis, and prepared the manuscript. Lexicon
Pharmaceuticals approved the decision to publish this manuscript.
Competing Interests: All of the authors of this paper were employed by Lexicon Pharmaceuticals and did this work as part of their employment. As employees
of this publicly traded company, they all receive stock options as part of their compensation. Lexicon has no program directed at Tmub1 and no patent pending
describing any part of the results of this publication. All of the above does not alter the authors’ adherence to all the PLoS ONE policies on sharing dataa n d
materials.
* E-mail: gye@lexpharma.com
Introduction
Tmub1 encodes for a protein, HOPS/DULP, containing
transmembrane domains and a ubiquitin-like domain (UBL)
[1,2]. Ubiquitin can be employed to modify proteins by either
single or multiple ubiquitin conjugation to mark them for
proteasomal destruction, endocytosis and binding to other
proteins [3–5]. Ubiquitin-like domain containing proteins are
generally divided into two categories: the ubiquitin-like modifiers,
such as SUMO, which can conjugate proteins similar to ubiquitin
[6–8], and the integral UBL domain-containing proteins (UDP)
that are not conjugatable. The functions of UDPs are believed to
be involved in a wide range of cellular processes. Some UDP
proteins function by binding to the 26S proteasome via their UBL
domain, whereas others function independent of the proteasome,
including roles in receptor trafficking [3,9,10]. The UBL
containing proteins Plic-1/ubiquilin-1 and GABARAP/ubiqui-
lin-2, both of which also contain a ubiquitin-associated domain
(UBA), were shown to regulate GABAA receptor cellular
localization and cell surface number [11–13]. Tmub1/HOPS
was reported to facilitate the recycling of AMPA receptors into
synaptic membrane in cultured primary neurons [14]. Tmub1/
HOPS was also found overexpressed during liver regeneration [1]
and is an essential constituent of centrosome assembly during cell
cycles in culture [15]. Like many UBL domain proteins, the
physiological and molecular function of Tmub1 is far from being
clear. To investigate the functions of Tmub1 in vivo, we performed
Tmub1 gene deletion in mice, as part of a collaborative effort
between Genentech and Lexicon Pharmaceuticals to analyze the
function of about 500 secreted and transmembrane proteins. The
resulting Tmub1 2/2 mice were put through an extensive
battery of assays to discover physiological and behavioral
phenotypes. We also examined the regional expression in brain
by the promoter reporter LacZ, the subcellular localization of
protein in HEK cells, and used a yeast two hybrid screen to look
for protein partners.
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Tmub1 KO mice appeared normal in terms of weight, length
and in a battery of physiological and metabolic assays (data not
shown) routinely run on all mice generated with genetic
deficiencies at Lexicon Pharmaceuticals [16]. General activity,
anxiety, motor coordination, acoustic startle, sensorimotor gating,
depressive-like behaviors, learning and memory, and acute and
tonic pain sensitivity did not differ between KO mice and WT
controls as assessed in the open field, stress-induced hyperthermia,
marble burying, inverted screen, pre-pulse inhibition, tail
suspension, trace fear conditioning, hot plate and formalin paw
assays (Table 1).
Significant differences in locomotor activity were noted between
WT and KO mice, with KO mice exhibiting higher activity
during the dark phase (mouse subjective day) of the L:D cycle in a
home-cage environment. This was very obvious in the initial
screening cohort and was seen in three additional cohorts created
and tested over a two-year period. Therefore, expression of the
phenotype was seen in multiple generations on the mixed
background strains used to create these mice. In one of the larger
cohorts, both males and females were monitored for circadian
home-cage activity for 2 weeks; the first week consisted of exposure
to a standard 12:12 L:D cycle (Figure 1A), and the second week
continuous darkness (D:D) (Figure 1B and 1C). There was a
significant effect of genotype observed during the dark phase of a
normal L:D cycle with KO mice exhibiting greater activity
[F(1,34)=5.1, P,0.05]. There was no significant effect of
genotype during the light phase. There was no significant effect
of sex or interaction of sex with other measures for any part of the
standard L:D testing. The greater amount of locomotor activity
during subjective day persisted into the D:D challenge. During
D:D challenge a significant effect of genotype was observed during
hours normally associated with darkness (subjective day)
[F(1,34)=5.2, P,0.05] and also a significant interaction of test
period (repeated measure; RM)6sex6genotype [F(6,204)=3.2,
P,0.01]. Analysis of the interaction revealed that during the D:D
challenge a significant increase in activity during the normally
dark period was observed in KO females. The increase in KO
males was not significant. Interestingly, a significant genotype
effect was also detected during the 12 hours normally associated
with the light phase (subjective night) during the D:D challenge
[F(1,34)=5.3, P,0.05]. During that time there was also a
significant interaction of test day (RM)6sex6genotype
[F(7,238)=3.3, P,0.01]. As during the normally dark periods,
the effect was significant only in females. Analysis of the
interaction also showed that changes in subjective night-time
activity during darkness challenge were observed starting on day 3
into the challenge. Visual inspection of the data found that
increased activity in females continued on into the first couple of
hours of the normally light phase (Figure 1B) before returning to
expected light phase levels.
Telemetric recording of locomotor activity, EEG, EMG, and
body temperature of mice in a home-cage environment provided
additional support for the increased locomotor activity occurring
only during subjective day (Figure S1A). The intensity of
locomotor activity (Figure S1B) calculated as the activity counts
per minute of wakefulness, was increased revealing an indepen-
dence of increased activity from increased wakefulness. The total
waking time of Tmub1 KO mice in the 12 hour dark phase was
greater, to 125.6%, while NREM and REM sleep times were
diminished, to 54.9% and 41.1%, respectively, compared to those
of WT cohort-mates (table 2). In an hour by hour comparison,
Tmub1 KO mice had significantly longer waking and shorter
NREM times from the third through the seventh, and also the
twelfth hour after the onset of darkness (Figure 2). In NREM, the
EEG power density distribution in Tmub1 KO and WT mice was
comparable, both in the light and dark phases (Figure S2A).
During waking as well, the EEG power density distribution (the
relative strength of specific EEG frequencies) was comparable in
Table 1. General behavioral characterization of Tmub1 KO
mice.
WT KO
Circadian (only females)
First 1 hour habituation 9006232 (6) 11096425 (10)
First 10 hours habituation 27136592 (6) 12785613996 (10)*
Average light cycle activity 7896387 (6) 8166929 (10)
Average dark cycle activity 23446882 (6) 15531622340 (10) #
Open Field
Total distance (cm) 25996813 (8) 284861036 (8)
Center Time Male 2846171 (4) 4456123 (4)
Center Time Female 5466101 (4) 4646190 (4)
Rearing 61629 (8) 39638 (8)
Basal Body Temperature
Female 37.3560.49 (4) 37.2560.48 (4)
Male 36.860.09 (4) 36.860.28 (4)
Stress-induced Hyperthermia
Only males 0.8860.39 (4) 1.0360.24 (4)
Marble burying
Males 7.366.8 (6) 8.665.9 (8)
Females 7.766.7 (7) 6.2567.3 (4)
Inverted Screen
Fell down (ratio) 0/8 (0%) 2/8 (25%)
Climbed up (ratio) 7/8 (88%) 3/8 (38%)
Hot Plate
Latency to respond, sec 10.264.8 (8) 11.3565.4 (8)
Acoustic Startle Response
120 dB 4686370 (8) 3716511 (8)
PPI (%)
pp4 17.7632 (7) 33.5616 (5)
pp8 49621 (7) 6568.3 (5)
pp12 50625 (7) 6467.5 (5)
pp20 68614 (7) 74624 (5)
Tail suspension
Immobility time, sec 224658 (7) 1866107 (6)
Fear conditioning
Pre-CS freezing (%) 4.066.5 (8) 12.9614.9 (8)
Post-CS cued freezing (%) 34629 (8) 35627 (8)
Formalin Paw (only males)
Phase 1 flinches 224684 (2) 1906124 (6)
Phase 2 flinches 3926378 (2) 3596327 (6)
Data are expressed as mean 6SD (N). Statistical analysis was performed for all
assays.
*- p,0.05.
#- p=0.07–0.09 from WT cohort mates (unpaired t-test). Mice with startle
amplitudes less than 100 were excluded from PPI analysis. Mice that climbed
tails were excluded from tail suspension analysis.
doi:10.1371/journal.pone.0011261.t001
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phases (Figure S2B). In the delta frequency range, a strong
component of NREM sleep, although the averaged EEG power
density in KO mice was numerically higher than that in WT mice,
the difference was not significant overall or for any single hour.
The expression of Tmub1 is reported to be high in the brain
and the protein product is found in all parts of brain examined by
western blot [14]. In situ hybridization of mouse brain reveals
mRNA expression at P7 in the hippocampus, thalamus,
cerebellum and cortex, and very low expression in adult brain
(http://www.stjudebgem.org) [17]. Our LacZ expression (Figure 3)
represents the activity of the endogenous Tmub1 promoter in the
adult mice, and under standard exposure of thin sections of a series
brain slices, expression of the mRNA is seen in the thalamus,
cerebellum, and cortex (Figure 3A). Cellular density of LacZ
reaction product was conspicuous in certain specific thalamic
nuclei (Figure 3B) including the ventral posterior and, lateral
geniculate nuclei (Figure 3C), and in the subthalamic nucleus and
zona incerta. The LacZ signal was weak and only in a restricted set
of cells in cortex (Figure 3D). In the cerebellum the blue LacZ
reaction product was intense in Purkinje cells and a few basket/
stellate cells (Figure 3E).
To discover the molecular function of Tmub1 we performed
yeast two hybrid screening using full-length Tmub1 as a bait to
identify proteins it binds specifically. Approximately 300 positive
yeast clones were isolated from the Pretransformed Human Brain
cDNA library. Of the seven proteins that hit more than twice, six
were not in frame or corresponded to untranslated regions.
Therefore, our attention was drawn to one that was present in
more than 10% of all positive yeast clones characterized (33
clones). Its sequence revealed a full length, in-frame open reading
frame encoding Calcium modulating cyclophilin ligand
(CAMLG/CAML). The cDNA’s encoding His-tagged Tmub1
and FLAG-tagged CAMLG were expressed in HEK293
(Figure 4A, B); co-immunoprecipitation experiments confirmed
their interaction in these mammalian cells (Figure 4C).
To see whether Tmub1 and CAMLG proteins colocalized when
expressed in HEK293 cells, immunostaining by anti-His tag and
anti-FLAG tag was performed. The two proteins partially co-
localized in the cytoplasmic region (Figure 4D).
Discussion
The ubiquitin-like domain containing proteins are expected to
have diverse roles in various biological processes. However, the
studies of functions for many members in this family are only
beginning. Tmub1 is one of a few UBL containing proteins that
possess transmembrane domains. In this report deletion of Tmub1
in mice resulted in a robust, but very circumscribed, behavioral
phenotype. Locomotor activity was greatly increased during
subjective day (dark phase) in a home-cage environment. We did
not observe this increased locomotor activity in other situations,
such as a novel open field. The increased locomotor activity was
concomitant with increased wakefulness as measured by EEG, but
was not simply due to increased wakefulness because the rate of
locomotor activity was also significantly increased. It is intriguing
that the increased locomotor intensity, during the dark period and
the very beginning of light period, did not continue during the
remaining light period although a substantial amount of waking
time still occurred. It will be interesting to determine how these
two effects – increased intensity of locomotor activity and
increased wakefulness – are related. Tmub1 KO mice were able
to maintain a largely normal circadian rhythm of locomotor
activity during a seven day complete darkness challenge, and
continued to show the hyperactivity primarily during the normally
dark periods. The female KO mice did extend the higher
locomotor activity into the first couple of hours of the normally
light period, but then returned to a low level appropriate for the
light period. In the 24 hr EEG analysis, KO mice exhibited
increased waking and decreased REM and NREM sleep during
dark phase, while producing comparable amounts of waking and
sleep during the light period. No abnormal EEG events were
observed.
As Tmub1 is strongly expressed in the thalamus, a structure
known to play roles in arousal and the expression of sleep and
wakefulness [18], we suggest the behavioral phenotype is a result
of altered neuronal activity in thalamus [19,20]. The cerebellum,
another area where Tmub1 is highly expressed, is not known for
generation of sleep rhythms; however correlations between
cerebellar gene expression with sleep and wakefulness have been
reported [21].
Tmub1 has been previously shown to facilitate the recycling of
GluR2 subunit of AMPA receptor to synaptic site [14]. The
authors suggested that this process may be mediated by the
interaction of GRIP and Tmub1/HOPS. They observed an
interaction of Tmub1 and GRIP in HEK293 cells, but not in a
yeast two-hybrid assay. It is possible that the interaction of Tmub1
with GluR2-GRIP is indirect and requires another mediator. In
our yeast two-hybrid screen we identified a novel binding partner,
CAMLG, for Tmub1. This was further confirmed by a co-
immunoprecipitation pulldown assay. CAMLG was first identified
as a cyclophilin B binding protein and shown to implicate
cyclophilin B in the calcium signal transduction pathway in T cell
activation [22]. A number of molecular interactors for CAMLG
have since been identified [23–29]. CAMLG was found to be
required for efficient EGF receptor recycling in studies from
Figure 1. Tmub1 deletion resulted in increased ambulatory activity, but largely normal circadian rhythm in both light:dark and
dark:dark protocols. A) Ambulatory counts during standard 12:12 L:D cycle. Data from male and female mice is combined on this graph since
there was no significant effect of sex using RM ANOVA. B) and C) Ambulatory counts during continuous darkness challenge for females and males.
*** - P,0.001, ** - P,0.01, * - P,0.05 (analysis of test period6sex6genotype interaction, Fisher LSD post-hoc following RM ANOVA).
doi:10.1371/journal.pone.0011261.g001
Table 2. Tmub1 deletion resulted in enhanced waking and
reduced NREM and REM time during dark period.
7am–7pm WT (minutes) KO (minutes)
(12 hr light period) Waking 262.23619.37 290.24624.30
REM 29.3064.90 22.2464.73
NREM 428.47617.15 407.52624.49
7pm–7am WT KO
(12 hr dark period) Waking 461.38621.76 579.46615.22 **
REM 10.9561.76 4.5061.18**
NREM 246.67620.34 136.04614.63**
Data presented as mean 6 s.e.m.
**p,0.01 in student t-test in comparison to WT.
doi:10.1371/journal.pone.0011261.t002
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CAMLG is also reported to be involved in recycling and endocytic
processing of GABAA receptors [28]. In a cortical culture, using
shRNA knockdown, this study revealed that the reduction of
CAMLG translated into reduced GABAA receptors on the
postsynaptic membrane and reduced GABA evoked current
density and frequency of spontaneous IPSCs. The effect of
CAMLG shRNA was specific to GABAA receptors since
glutamate evoked current and spontaneous EPSCs remained
unaltered in these neurons. The impact of GABAA receptor
modulation, in sleep physiology, is widely accepted. It is interesting
to speculate that Tmub1 and CAMLG proteins could work in
concert to regulate cycling of receptors, such as GABA and
glutamate receptors, to synapticmembranes in neuronal circuits
critical for the control of locomotor activity and wakefulness in
mice. Their modulation may prove to be interesting avenues for
sleep research.
In conclusion our study reveals that Tmub1 directly binds to
CAMLG protein and the physiological function of Tmub1 is in
locomotor activity and wakefulness, likely via its molecular
function in thalamic neuronal circuits.
Materials and Methods
Ethics Statement
All mice analyzed were maintained in an AAALAC-accredited
animal facility at Lexicon Pharmaceuticals Inc. Mice were housed
in a barrier facility at 22uC on a fixed 12-hour light and 12-hour
dark cycle with free access to water and standard rodent chow (9F
5021; Purina, St Louis, MO). Procedures involving animals were
conducted in conformity with the Institutional Animal Care and
Use Committee guidelines that are in compliance with the state
and federal laws and the standards outlined in the Guide for the
Care and Use of Laboratory Animals. All experiments were
approved by the Institutional Animal Care and Use Committee of
Lexicon Pharmaceuticals, Inc.
Knockout generation
The Tmub1 knockout line was generated by homologous
recombination. The targeting vector was derived using the
Lambda KOS system [31]. The Lambda KOS phage library,
arrayed as 96 superpools, was screened by duplex-PCR using a
primer pair upstream of exon 1 (Tmub1-1 [59-CTCATAGGGA-
Figure 2. Tmub1 deletion resulted in enhanced waking and reduced REM and NREM sleep time during dark period. Mice were singly
caged throughout the EEG/EMG recording in light cycle from 7 a.m. to 7 p.m. Dark phase is indicated by the black horizontal bars along the x-axis of
clock time. Y-axis are minutes of waking, REM, or NREM sleep per one hour epoch. Data for KO and WT are shown in gray and in black respectively.
Asterisks and horizontal lines above markers indicate significant difference between KO and WT group (p,0.05 in student t-test).
doi:10.1371/journal.pone.0011261.g002
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CTCCTGACACC]) and a primer pair just downstream of exon 3
(Tmub1-8 [59-GGTCACTCTCTCAGCTGGTCTTG] and
Tmub1-9 [59-CTAGGTCCTGAGTGCTCAAGCTAC]). Exons
defined with reference to accession NM_022418.3. PCR-positive
phage superpools were plated and screened by filter hybridization
using the 410bp PCR product derived from primers Tmub1-5 [59-
GACTACAGGATGCTGCATCCTGG] and Tmub1-6 [59-
CTGTGTCAGGCTCTGGCTGTGC] as a probe. One genomic
clone, pKOS-65, was isolated from the library and confirmed by
sequence analysis. To generate the target vector, first gene-specific
arms (59- CTCTCTAGCTCCTTAGCACCTCTGGCAGCAG-
CACG-39 and 59- GCCTCCACGGGCTTTTGGCAGTGTAG-
CCAGCCCCTC-39) were appended by PCR to a yeast selection
cassette containing the URA3 marker. The yeast selection cassette
and pKOS-65 were co-transformed into yeast and clones that had
undergone homologous recombination to replace the 1005bp
genomic region containing exons 2–3 with the yeast selectable
marker were isolated. The yeast cassette was subsequently
replaced with an ES cell selection cassette containing the reporter
gene LacZ. The targeting vector was linearized by NotI digest and
electroporated into 129/SvEv
Brd (Lex-1) ES cells (Figure 5A).
G418/FIAU-resistant ES cell clones were isolated and correctly
targeted clones were identified and confirmed by Southern
analysis. A 509bp 59external probe was generated outside the
pKOS-65 arm of homology using PCR primers Tmub1-26 (59-
TTGAAGACCTGCTAGGGCTAC) and Tmub1-27 (59-ATTA-
TACCACACGGCAACTC). A 565bp 39external probe was
generated using PCR primers Tmub1-23 (59-CTTAGCTAG-
GATGGCTCACG) and Tmub1-24 (59-CCAACACAGCT-
TTGCTATCG). Southern analysis using the 26+27 59probe
detected a 12.8kb wildtype band and a 4.3kb targeted band in
ApaLI digested genomic DNA while the 23+24 39probe detected a
12.8kb wildtype band and a 10.1kb targeted band in ApaLI
Figure 3. Tmub1 expression in adult brain was detected using B-Gal activity driven under the tmub1 promoter as described in
Materials and Methods. A) Low magnification image of a series of thin brain section from KO (left side hemisphere) and WT (right side
hemisphere) mice stained for B-Gal activity. LacZ expression was detected at low levels in the cortex (Cx) and higher levels in the thalamus (Th) and
cerebellum (Cb). B), C), and D) Higher magnification of the thalamus, dorsal lateral geniculate nucleus (dLGN) in the Th, and Cx. E) High levels of LacZ
in the Purkinje cell layer (pc) adjacent to the molecular layer (ml) and no detectable expression in the granule cells (gcl). (Original magnification:A ,
0.76;B ,5 6; C, D, and E, 206).
doi:10.1371/journal.pone.0011261.g003
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were microinjected into C57BL/6 (albino) blastocysts. Resulting
chimeras were mated to C57BL/6 (albino) females to generate
mice that were heterozygous (Tmub1 +/2) for the exon 2–3
deletion mutation. Heterozygous mice were intercrossed, yielding
Tmub1 2/2 mice.
Genotyping
Genomic DNAs were obtained from brain of wild type and
homozygous animals. Gene specific primers pair (A:
GCCCTTCTTTCCCCTGACCGCTACC and B: TGCGC-
CTTGGGGAATGAGGTCCAGA) together with neomycin spe-
cific and gene specific primer pair (C: GGCTGACCGCTT-
Figure 5. Knockout genetics. A) Construction of the Tmub1 gene targeting vector and Southern strategies for confirmation. A schematic
representation of the Tmub1 locus is shown, including relevant ApaLI restriction sites used for confirmation Southern hybridization analysis. As
described in the methods section, a genomic clone was isolated (pKOS-65) containing the exon 2–3 region to be deleted. A yeast-mediated
homologous recombination (illustrated by large Xs) step first replaced the exon 2–3 region of the genomic clone with a yeast selection cassette. The
final targeting vector was completed by replacing the yeast selection cassette with an ES selection cassette containing the LacZ reporter gene and a
gene for G418 resistance. The 59 and 39 external probes used for Southern hybridization analysis were designed outside the target vector arms of
homology and were generated by genomic PCR. Locations of the oligonucleotide primers used for genotyping animals are also noted. B) Southern
hybridization demonstrating proper targeting of the ES cell clones. Genomic DNA was digested with ApaLI and hybridized with the 39 external probe
(see Method). Two correctly targeted clones were identified by Southern hybridization using the 59 or 39 external probes described in the text. Clones
2B8 and 2C9 were injected into blastocysts and clone 2B8 ultimately achieved germline transmission. C) Characterization of the knock out animals.
Results of multiplex PCR described in the method show absent of wild type band and present of mutant band in two homozygous mice, while
opposite results were seen in the wild type animals. Invitrogen’s 100bp ladder was used as size marker.
doi:10.1371/journal.pone.0011261.g005
Figure 4. Interaction of Tmub1 and CAMLG in mammalian cells. A) His-Tmub1 and Tmub1-His were expressed in HEK293. Tmub1-His
construct generated two products consistent to previous reports (Yang et al 2008; Della Fazia et al. 2005). B) FLAG-CAMLG was expressed HEK293.
The molecular weight ladder is indicated as in kilodaltons. C) Tmub1 bound CAMLG when they were co-expressed in the HEK cells. Upper panel
shows His-Tmub1 and Tmub1-His can be pulled down by anti-His affinity column; lower panel showed FLAG-Camlg was also pulled down only in the
presence of Tmub1. in: input of lysate of transfected cells. Ub: fraction unbound to affinity column. b: bound to affinity column. D) Confocal images
show Tmub1 and CAMLG were colocalized in HEK293 at cytoplasmic location. Green: anti-Flag for Flag-CAMLG; Red: anti-His for His-Tmub1, Blue:
DAPI.
doi:10.1371/journal.pone.0011261.g004
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(+/+) and mutant (2/2) Tmub1 allele respectively in multiplex
PCR reaction using High Fidelity polymerase (BioRad) according
to the manufacture’s instruction. The wild type band is 148bp
while mutant band is 271bp (Figure 5C). PCR was carried out at
initial denaturing step of 98uC for 2.5 min followed by 40 cycles of
98uC (15 sec), 69uC, (20 sec), 72uC (20 sec) then a final
amplification step at 72uC for 1 minute. PCR products were
subject to sequencing using 37306l capillary sequencer (Applied
Biosystems).
Behavior assays
Subjects. Animals used for all studies were male (M) and
female (F) knockout (KO) and wild type (WT) cohort mates bred in
a mixed (C57BL/6J-Tyr
c-Brd6129S5/SvEvBrd) genetic background
at Lexicon Pharmaceuticals. All mice were maintained under a
standard light/dark cycle from 7 am to 7 pm. They were housed in
groups of five in 30620620 cm acrylic cages with food and water
freely available.
Mice were tested in a standardized battery of behavioral tests. A
comprehensive phenotypic analysis included a wide range of
behaviors as well as assays for cardiac, immune system, endocrine,
and ophthalmic function. Cohort 1 (4 WT and 8 KO) was run
through this standard phenotypic analysis battery routinely used at
Lexicon Pharmaceuticals [16].
Circadian locomotor activity. Circadian locomotor activity
was measured by a San Diego Instruments cage rack Photobeam
Activity System (PAS-Home Cage, San Diego Instruments, San
Diego, CA). Mice were individually housed starting at 5 pm on the
first day of testing. The circadian chambers measured
48.2 cm626.5 cm and allowed free access to food and water.
For one week, animals were exposed to a regular 12-hour light/
dark cycle (L:D) with lights turning on at 7 am and turning off at 7
pm. Starting on day 7 the animals were monitored for an
additional week in complete darkness (D:D). Activity was recorded
in one-hour intervals throughout testing.
Behavior data analysis. The Statistica 8.0 software package
(StatSoft, Inc., Tulsa, OK) was used to determine significant
differences between groups. Circadian activity data was analyzed
using repeated measures ANOVA with sex and genotype as main
effects and days across light cycle or days across dark cycle as
repeated measure. Analysis of the same design was performed for
continuous darkness challenge for periods normally associated with
light cycle and periods normally associated with dark cycle. Where
no significant effect of sex or sex6genotype interaction was
determined the data from both sexes was analyzed together.
Where significant interactions were determined Tukey HSD or
LSD post-hoc analysis was performed to further analyze the
differences between groups. Where no significant interactions were
determined only the overall effects of genotype and/or sex are
reported. The data from initial phenotypic evaluation was analyzed
using unpaired two-tailed t-tests. The data is presented as Mean 6
SEM. The lines on the dot-plot graphs represent group averages.
EEG/EMG/activity recording. A cohort of 19 naive male
mice (10 months old, 9 KO and 10 WT littermates) were surgically
implanted with F-20-EET biopotential transmitters (DSI, Data
Science International, Wisconsin, USA) according to DSI EET
device surgical manual for rodents. Briefly, mice were anesthetized
with isoflurane. After the transmitter was placed on top of the
intestines, biopotential leads were directed caudally to a dorsal
neck incision through a subcutaneous tunnel. The animal was then
placed in a stereotaxic apparatus for cranial immobilization. The
skull was perforated through the bone but before the dura
membrane at 2 mm either side of the sagittal suture and 1mm
posterior to the bregma suture on left side and 1 mm anterior to
the lambda suture on the right for ground and EEG leads
implantation. EMG leads were secured in cervical trapezius
muscles. Post-surgical analgesia (buprenorphine 0.05–0.1mg/kg)
and replenishing fluid (saline 0.5 m)l were administered
subcutaneously.
Following 10–14 days of recovery from surgery mice were
transferred into the EEG lab and acclimated for 2 days before
experiment. After acclimation EEG, EMG, body temperature,
and locomotor activity data were continuously acquired for
24 hours with DataquestART 4.0 (Data Sciences International)
data acquisition system. EEG and EMG signals were amplified
and filtered at 0.3–30 Hz and 20–200 Hz respectively, digitized at
a sampling rate of 250 Hz. Locomotor activity data were collected
as relative animal movement counts per minute. Acquired EEG/
EMG data were visually inspected for a successful recording then
autoscored with SleepSign for Animal software (Kissei Comtec Co.
Japan) into three different vigilance states: NREM, REM or
Waking. Averaged EEG power spectral was computed from all 10s
epochs scored into the same vigilance state during the 12 hour
light or dark phase. EEG power density was calculated from the
power spectral at each frequency as percentage of sum of all
frequency.
LacZ histochemistry
LacZ gene as a reporter is within the targeting cassette. The
LacZ gene expression represents the activity of the endogenous
Tmub1 promoter. The LacZ expression was measured by 5-
bromo-4-chloro-3-indolyl-D galactopyranoside (x-gal) reaction on
4mm brain slices of knockout and wild type mice as described by
Vogel et al [32].
Immunohistochemistry
Four percent paraformaldehyde fixed, paraffin-embedded tissue
sections at 4 mm were mounted on positively charged glass slides
(Superfrost Plus, Fisher Scientific, Pittsburgh, PA) and first
deparaffinized in xylene and re-hydrated in PBS before incubating
in the primary antibody. Endogenous peroxidase activity was
blocked byincubation in3.0%hydrogenperoxideinPBSfor5 min.
Tissue sections werethen blocked with 20% normal horse serum for
10 minutes and then primary antibody mouse anti-GAD67
(MAB5406; Chemicon (Millipore) at 1:500 was applied for 1 hour
at 37 degrees centigrade. After rinsing, sections were incubated for
one hour in a 1:500 dilution of the biotinylated secondary antibody
(Horse anti-Mouse IgG, Vector, Burlingame, CA). Bound antibod-
ies were detected by an avidin-biotin complex method (Elite ABC
Kit, Vector) with 3,39-diaminobenzidine as chromogenic substrate
following the manufacturer’s instructions. Negative controls includ-
ed substitution of non-immune serum for the primary antibody and
omission of the primary antibody. Sections were mounted with
Permount (Fisher Scientific, Pittsburgh, PA).
Yeast Two-hybrid screening
Tmub1 full-length cDNA was cloned into yeast expression
vector pGBKT7. The pGBKT7-Tmub1 plasmid was transformed
into yeast strain AH109. The Yeast Two-hybrid screening was
carried out according to the manufacturer’s protocol (Clontech)
using Pretransformed Human Brain MATCHMAKER cDNA
library (Clontech). The Human cDNA inserts were cloned into
yeast expression vector pACT2. There are 5610
6 independent
clones in this library and approximately 8.2610
6 clones were
screened. Positive clones were selected on plates supplemented
with X-a-Gal lacking leucine, tryptophan, and histidine. Positive
clones were used as templates, and cDNA fragments of the
Tmub1 Knockout and Interaction
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flanking cDNA inserts in vector pACT2.
Biochemistry
Tmub1 was cloned into pIRES-puro2 expression vector with
66His at N-terminus or C-terminus. CAMLG was also cloned
into pIRESpuro2 vector with Flag tag at N-terminus. The
constructs were transiently transfected to HEK293 cells and
expression of recombinant proteins was confirmed by western blot
using anti-His (Qiagen) and anti-Flag (Sigma) antibodies. Cells
were extracted in lysis buffer (20mM Tris pH8.0, 150mM NaCl,
1% Triton X-100, 1mM EDTA, 16protease inhibitor cocktail) to
obtain cell lysate. The coimmunoprecipitation was carried out
using anti-His or anti-Flag antibody in cell lysate and the anti-Flag
or anti-His antibodies were used to confirm the presence of
Tmub1 and CAMLG in the immunoprecipitates.
Supporting Information
Figure S1 Deletion of Tmub1 resulted in increased locomotor
activity. Mice were singly caged throughout the EEG/EMG/BT/
activity recording with light cycle from 7 a.m. to 7 p.m. Dark
phase is indicated by the black horizontal bars along the x-axis of
clock time. Data for KO and WT are shown in gray and in black
respectively. A) Tmub1 deletion resulted in dramatic increase in
locomotor activity during dark phase. Y-axis represents the
averaged activity counts in the same genotype group for each
hour. B) Tmub1 deletion resulted in significant increase in
locomotor activity intensity during dark phase. Locomotor activity
intensity was calculated as activity counts per waking minutes. Y-
axis represents the averaged activity counts per waking minutes in
the same genotype group for each hour.
Found at: doi:10.1371/journal.pone.0011261.s001 (0.19 MB TIF)
Figure S2 Deletion of Tmub1 did not affect EEG power density
distribution across different frequency bands in NREM (A) and
waking (B) state. EEG power density is computed from averaged 2-
hour FFT (fast Fourier transform) and expressed as percentage of
spectral power in delta, theta, alpha, beta, and gamma frequency
over total spectral power in NREM state. Data for KO and WT are
shown in gray and in black respectively. Mice were singly caged
throughout the EEG/EMG/BT/activity recording with light cycle
from 7 a.m. to 7 p.m. Dark phase is indicated by the black
horizontal bars along the x-axis of clock time.
Found at: doi:10.1371/journal.pone.0011261.s002 (0.23 MB TIF)
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